These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 11385619

  • 1. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L, Willcox BE, Jones EY, Gillespie G, Njai H, Sabally S, Jaye A, DeGleria K, Rostron T, Lepin E, McMichael A, Whittle H, Rowland-Jones S.
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [Abstract] [Full Text] [Related]

  • 2. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
    Goulder PJ, Brander C, Annamalai K, Mngqundaniso N, Govender U, Tang Y, He S, Hartman KE, O'Callaghan CA, Ogg GS, Altfeld MA, Rosenberg ES, Cao H, Kalams SA, Hammond M, Bunce M, Pelton SI, Burchett SA, McIntosh K, Coovadia HM, Walker BD.
    J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
    Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD.
    J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
    [Abstract] [Full Text] [Related]

  • 4. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    Altfeld MA, Trocha A, Eldridge RL, Rosenberg ES, Phillips MN, Addo MM, Sekaly RP, Kalams SA, Burchett SA, McIntosh K, Walker BD, Goulder PJ.
    J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
    [Abstract] [Full Text] [Related]

  • 5. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
    Goulder PJ, Tang Y, Pelton SI, Walker BD.
    J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606
    [Abstract] [Full Text] [Related]

  • 6. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR, Visawapoka U, Tovanabutra S, Mason CJ, Birx DL, McCutchan FE, Cox JH.
    BMC Immunol; 2006 Apr 18; 7():8. PubMed ID: 16620386
    [Abstract] [Full Text] [Related]

  • 7. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM, HIVNET 028 Study Team.
    J Immunol; 2004 Oct 01; 173(7):4607-17. PubMed ID: 15383595
    [Abstract] [Full Text] [Related]

  • 8. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 9. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S, Kaleebu P, Krausa P, Goulder P, French N, Collin B, Blanchard T, Whitworth J, McMichael A, Gotch F.
    AIDS; 1998 Apr 16; 12(6):571-9. PubMed ID: 9583596
    [Abstract] [Full Text] [Related]

  • 10. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS, Tomiyama H, Inagawa T, Ida S, Oka S, Takiguchi M.
    AIDS Res Hum Retroviruses; 2003 Jun 16; 19(6):503-10. PubMed ID: 12882660
    [Abstract] [Full Text] [Related]

  • 11. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD.
    J Virol; 1999 Dec 16; 73(12):10191-8. PubMed ID: 10559335
    [Abstract] [Full Text] [Related]

  • 12. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.
    J Virol; 2004 Feb 16; 78(3):1324-32. PubMed ID: 14722287
    [Abstract] [Full Text] [Related]

  • 13. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T.
    Nat Med; 1995 Jan 16; 1(1):59-64. PubMed ID: 7584954
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR, deSouza M, Chanbancherd P, Bernstein W, Birx DL, Cox JH.
    J Virol; 2002 May 16; 76(10):4971-86. PubMed ID: 11967314
    [Abstract] [Full Text] [Related]

  • 15. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B, Mori M, Tanaka M, Nishimura S, Miura T, Pathipvanich P, Sawanpanyalert P, Ariyoshi K.
    PLoS One; 2012 May 16; 7(7):e41696. PubMed ID: 22848569
    [Abstract] [Full Text] [Related]

  • 16. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
    Durali D, Morvan J, Letourneur F, Schmitt D, Guegan N, Dalod M, Saragosti S, Sicard D, Levy JP, Gomard E.
    J Virol; 1998 May 16; 72(5):3547-53. PubMed ID: 9557634
    [Abstract] [Full Text] [Related]

  • 17. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
    van Baalen CA, Klein MR, Huisman RC, Dings ME, Kerkhof Garde SR, Geretti AM, Gruters R, van Els CA, Miedema F, Osterhaus AD.
    J Gen Virol; 1996 Aug 16; 77 ( Pt 8)():1659-65. PubMed ID: 8760412
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope.
    Gotch F, McAdam SN, Allsopp CE, Gallimore A, Elvin J, Kieny MP, Hill AV, McMichael AJ, Whittle HC.
    J Immunol; 1993 Sep 15; 151(6):3361-9. PubMed ID: 7690804
    [Abstract] [Full Text] [Related]

  • 19. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Sep 15; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 20. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ.
    J Immunol; 2004 Aug 01; 173(3):2126-33. PubMed ID: 15265949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.